137 related articles for article (PubMed ID: 623128)
1. Granulocytopenia in hospitalized patients: I. Prognostic factors and etiology of fever.
Gurwith MJ; Brunton JL; Lank BA; Ronald AR; Harding GK
Am J Med; 1978 Jan; 64(1):121-6. PubMed ID: 623128
[TBL] [Abstract][Full Text] [Related]
2. The relationship of fever, granulocytopenia and antimicrobial therapy to bacteremia in cancer patients.
Gill FA; Robinson R; Maclowry JD; Levine AS
Cancer; 1977 Apr; 39(4):1704-9. PubMed ID: 856452
[TBL] [Abstract][Full Text] [Related]
3. Granulocytopenia in hospitalized patients. II. A prospective comparison of two antibiotic regimens in the empiric therapy of febrile patients.
Gurwith M; Brunton JL; Lank B; Ronald AR; Harding GK; McCullough DW
Am J Med; 1978 Jan; 64(1):127-32. PubMed ID: 623129
[TBL] [Abstract][Full Text] [Related]
4. Management of infections in children with cancer.
Barson WJ; Brady MT
Hematol Oncol Clin North Am; 1987 Dec; 1(4):801-39. PubMed ID: 3323184
[TBL] [Abstract][Full Text] [Related]
5. Improved prognosis for granulocytopenic patients with gram-negative bacteremia.
Love LJ; Schimpff SC; Schiffer CA; Wiernik PH
Am J Med; 1980 May; 68(5):643-8. PubMed ID: 7377220
[TBL] [Abstract][Full Text] [Related]
6. Infectious episodes in severely granulocytopenic patients.
van der Meer JW; Alleman M; Boekhout M
Infection; 1979; 7(4):171-5. PubMed ID: 511334
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).
Viscoli C; Bruzzi P; Castagnola E; Boni L; Calandra T; Gaya H; Meunier F; Feld R; Zinner S; Klastersky J
Eur J Cancer; 1994; 30A(4):430-7. PubMed ID: 8018397
[TBL] [Abstract][Full Text] [Related]
8. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients.
Gurwith MJ; Brunton JL; Lank BA; Harding GK; Ronald AR
Am J Med; 1979 Feb; 66(2):248-56. PubMed ID: 371396
[TBL] [Abstract][Full Text] [Related]
9. Persistent fever after recovery from granulocytopenia in acute leukemia.
Talbot GH; Provencher M; Cassileth PA
Arch Intern Med; 1988 Jan; 148(1):129-35. PubMed ID: 3422147
[TBL] [Abstract][Full Text] [Related]
10. A study of the value of simple protective isolation in patients with granulocytopenia.
Nauseef WM; Maki DG
N Engl J Med; 1981 Feb; 304(8):448-53. PubMed ID: 7005682
[TBL] [Abstract][Full Text] [Related]
11. [Fever in neutropenic patients: analysis of 109 episodes and 15 superinfections (author's transl)].
Baro J; Richard C; Esteban J; Iriondo A; Conde E; Garijo J; Zubizarreta A
Sangre (Barc); 1981; 26(4):417-26. PubMed ID: 7292225
[No Abstract] [Full Text] [Related]
12. Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
JAMA; 1994 Oct; 272(15):1183-9. PubMed ID: 7933348
[TBL] [Abstract][Full Text] [Related]
13. Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients.
Eggimann P; Glauser MP; Aoun M; Meunier F; Calandra T
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():151-63. PubMed ID: 8150759
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
[TBL] [Abstract][Full Text] [Related]
15. Empiric therapy with amphotericin B in febrile granulocytopenic patients.
Walsh TJ; Lee J; Lecciones J; Rubin M; Butler K; Francis P; Weinberger M; Roilides E; Marshall D; Gress J
Rev Infect Dis; 1991; 13(3):496-503. PubMed ID: 1866556
[TBL] [Abstract][Full Text] [Related]
16. Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever.
Steinshamn S; Brekke OL; Waage A
Br J Haematol; 1995 Apr; 89(4):719-24. PubMed ID: 7772508
[TBL] [Abstract][Full Text] [Related]
17. Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients.
Pegram PS; Phair JP; McMahan R; Murphy RL; Gordon LI; Washton H; Faubion C; Saviteer S; Cohen MS
J Antimicrob Chemother; 1989 Oct; 24(4):591-604. PubMed ID: 2693432
[TBL] [Abstract][Full Text] [Related]
18. Empiric treatment of infection during granulocytopenia.
Klastersky J
Ann Oncol; 1990 Jul; 1(4):255-61. PubMed ID: 2265135
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G.
Oyen WJ; Claessens RA; Raemaekers JM; de Pauw BE; van der Meer JW; Corstens FH
J Clin Oncol; 1992 Jan; 10(1):61-8. PubMed ID: 1727927
[TBL] [Abstract][Full Text] [Related]
20. Increase in interleukin-6 serum level preceding fever in granulocytopenia and correlation with death from sepsis.
Steinmetz HT; Herbertz A; Bertram M; Diehl V
J Infect Dis; 1995 Jan; 171(1):225-8. PubMed ID: 7798669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
